Keynote with panel
Drug safety priorities across the product lifecycle
Washington, DC, Key Bridge Marriott , United States
Broad spectrum of drug safety priorities across the product lifecycle
High level networking with industry practitioner decision makers
Debates on real-life practices over 2 intensive days
Meet the speakers
Head of Risk Management, Global Pharmacovigilance at AbbVie
Daniel Naranjo, MD
Associate Medical Director at Takeda
Global Pharmacovigilance, Head TA Oncology - ICSR Processing at Bayer
Dr Alexander Kluczka is Global Head of ICSR Processing Oncology at Bayer HealthCare, a company managing 500,000 Adverse Event case cycles per year. He leads an integrated team of 80 case processors an
VP of Global Patient Safety, VP of Global Pharmacovigilance and Medical Device Vigilance at Baxter
Jay Ehrlich is Vice President, Global Patient Safety, responsible for the groups who monitor Baxter’s drug, biologic, and medical device products for patient safety issues, communicating and minimiz
Who should attend
News from the industry
Facts from 2016
Sponsors & Partners
This two-day training workshop provides an understanding of the essential elements and requirements for the implementation of Good Clinical Practices and Good Pharmacovigilance Practices in three key global geographical regions: the US, the EU and Latin America.
The 10th annual conference presents a high-level meeting focused on the best ways how to translate strategic portfolio priorities into tactical actions.
For the upcoming Project and Portfolio Management for Pharma and Biotech Conference, Fleming presents a high-level meeting building on more than a decade of experience in running global Pharma PPM events worldwide.
One of our sales representatives will call you according to your preferences.
Thank you for your interest.
We appreciate your interest in this topic. The download should start automatically.
Your payment was successfull.
You should receive link to download your recording shortly.
Your friends have invites in their inbox.